Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

A Preview Of Mirum Pharmaceuticals's Earnings

Mirum Pharmaceuticals (NASDAQ:MIRM) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement.

Analysts estimate that Mirum Pharmaceuticals will report an earnings per share (EPS) of $-1.34.

Mirum Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $1.99, which was followed by a 3.9% drop in the share price the next day.

Here's a look at Mirum Pharmaceuticals's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.34 -1.73 -0.69
EPS Actual -1.65 -1.55 -1.45 1.68
Price Change % -3.9% 2.58% 1.1% 5.48%

Stock Performance

Shares of Mirum Pharmaceuticals were trading at $24.01 as of May 03. Over the last 52-week period, shares are up 32.77%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Mirum Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.